Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)

Clinical trial NCT01370694 · TERMINATED

Trial details

NCT number: NCT01370694
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2011-08-19
Primary completion: 2014-12-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.